BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1884023)

  • 21. Interferon-gamma enhances growth factor-dependent proliferation of clonogenic cells in acute myeloblastic leukemia.
    Murohashi I; Hoang T
    Blood; 1991 Aug; 78(4):1085-95. PubMed ID: 1714325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
    Kunieda Y
    Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic suppression of the clonogenicity of U937 leukemic cells by combinations of recombinant human interleukin 4 and granulocyte colony-stimulating factor.
    Maekawa T; Sonoda Y; Kuzuyama Y; Inazawa J; Kimura S; Nakamichi K; Abe T
    Exp Hematol; 1992 Nov; 20(10):1201-7. PubMed ID: 1385197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engagement of interleukin-7 receptor stimulates tyrosine phosphorylation, phosphoinositide turnover, and clonal proliferation of human T-lineage acute lymphoblastic leukemia cells.
    Dibirdik I; Langlie MC; Ledbetter JA; Tuel-Ahlgren L; Obuz V; Waddick KG; Gajl-Peczalska K; Schieven GL; Uckun FM
    Blood; 1991 Aug; 78(3):564-70. PubMed ID: 1650261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
    Nara N
    Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
    Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
    Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Philadelphia-chromosome-positive human leukemia in SCID mouse model with herbimycin A, bcr-abl tyrosine kinase activity inhibitor.
    Honma Y; Matsuo Y; Hayashi Y; Omura S
    Int J Cancer; 1995 Mar; 60(5):685-8. PubMed ID: 7860143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-4 and TNF-alpha-mediated proliferation of the human megakaryocytic line M-O7E is regulated by induced autocrine production of GM-CSF.
    Wadhwa M; Dilger P; Meager A; Walker B; Gaines-Das R; Thorpe R
    Cytokine; 1996 Dec; 8(12):900-9. PubMed ID: 9050748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative and differentiative effects of recombinant interleukin-4 on a granulocyte colony-stimulating factor-dependent myeloblastic leukemic cell line.
    Imai Y; Nara N; Tohda S; Nagata K; Suzuki T; Nagasawa M; Murohashi I; Aoki N
    Blood; 1991 Jul; 78(2):471-8. PubMed ID: 2070083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.
    Li Y; Valeriote F; Chen B
    Exp Hematol; 1996 Feb; 24(2):94-100. PubMed ID: 8641372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic and molecular analysis of Ph1-chromosome-positive acute lymphoblastic leukemia cell lines.
    Miyagi T; Ohyashiki J; Yamato K; Koeffler HP; Miyoshi I
    Int J Cancer; 1993 Feb; 53(3):457-62. PubMed ID: 8428799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autocrine and paracrine growth control by granulocyte-monocyte colony-stimulating factor of acute lymphoblastic leukemia cells.
    Freedman MH; Grunberger T; Correa P; Axelrad AA; Dube ID; Cohen A
    Blood; 1993 Jun; 81(11):3068-75. PubMed ID: 8499641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells.
    Makrynikola V; Kabral A; Bradstock KF
    Exp Hematol; 1991 Aug; 19(7):674-9. PubMed ID: 1893954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production.
    Brooks B; Chapman K; Lawry J; Meager A; Rees RC
    Clin Exp Immunol; 1990 Dec; 82(3):583-9. PubMed ID: 2124961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
    Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
    Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.